Ravelcare: No IPO Fund Use Deviation for H1 FY27

Ravelcare Ltd has filed its Statement of Deviation or Variation in Utilisation of Funds for the half-year ended September 30, 2026. The company confirms that there has been no deviation or variation in the utilization of proceeds from its Initial Public Offer (IPO) compared to the objects stated in the prospectus. The statement was reviewed by the Audit Committee and taken on record by the Board of Directors on November 13, 2026. The statutory auditors, Ratan Chandak & Co LLP, have certified that the utilization details match the company's unaudited books of accounts. Key areas of fund utilization include marketing and advertisement expenses (₹896.29 Lacs), general corporate purposes (₹213.21 Lacs), and issue expenses (₹219.10 Lacs).